GemPharmatech Co., Ltd. (SHA:688046)
China · Delayed Price · Currency is CNY 18.39
+0.05 (0.27%)
At close: Jan 22, 2026
GemPharmatech Market Cap
GemPharmatech has a market cap or net worth of 7.67 billion as of January 22, 2026. Its market cap has increased by 38.73% in one year.
Market Cap
7.67B
Enterprise Value
6.80B
Revenue
752.70M
Ranking
n/a
PE Ratio
62.35
Stock Price
18.39
Market Cap Chart
Since April 25, 2022, GemPharmatech's market cap has increased from 7.59B to 7.67B, an increase of 1.08%. That is a compound annual growth rate of 0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 7.54B | 19.73% |
| Dec 31, 2025 | 6.30B | 19.98% |
| Dec 31, 2024 | 5.25B | -36.47% |
| Dec 29, 2023 | 8.26B | -16.22% |
| Dec 30, 2022 | 9.86B | 30.00% |
| Apr 25, 2022 | 7.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing Vazyme Biotech | 8.51B |
| Shanghai Medicilon | 8.31B |
| Zhejiang Ausun Pharmaceutical | 8.15B |
| Wuhan Keqian Biology Co.,Ltd | 7.62B |
| Suzhou Fengbei Biotech Stock | 7.26B |
| Beijing Konruns Pharmaceutical | 6.93B |
| R&G PharmaStudies | 6.68B |
| Kexing Biopharm | 6.67B |